At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
PneumoniaCheckdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Detection of SARS-CoV-2 RNA and Biomarkers in Coughed Droplets From Patients With COVID-19 and Controls
In Brief
A clinical study evaluating PneumoniaCheck for Covid19. Completed, enrolled 69 participants across 4 sites.
Detailed Summary
The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participants will collect cough specimens over a 24 hour period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesUnited States
CollaboratorsGeorgia Tech Foundation
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartApr 2021
First PostedJun 2021
Primary CompletionAug 2022
TodayJul 2026
First PostedJun 3, 2021
Enrollment StartApr 14, 2021
Primary CompletionAug 5, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.1 years ago
Interventions
PneumoniaCheckdevice
Participants are asked to do 5 sets of 10 coughs, with at least 15 minutes between sets, into the PneumoniaCheck device.